Want to join the conversation?
$PFE 2Q15 Call: ForEx negatively impacted reported revenues by approx. $1Bil or 8% and positively impacted adjusted cost of sales, adjusted SI&A expenses and adjusted R&D expenses in the aggregate by $518MM or 7%. ForEx negatively impacted adjusted diluted EPS by approx. $0.06 compared with the year ago quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.